APTINYX
Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.
APTINYX
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Evanston, Illinois, United States
Country:
United States
Website Url:
http://www.aptinyx.com
Total Employee:
51+
Status:
Active
Contact:
(847)871-0377
Email Addresses:
[email protected]
Total Funding:
268.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Amazon IPv6 ReCAPTCHA
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Aptinyx
Longitude Capital
Longitude Capital investment in Series B - Aptinyx
Beecken Petty O'Keefe & Company
Beecken Petty O'Keefe & Company investment in Series B - Aptinyx
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Aptinyx
Adams Street Partners
Adams Street Partners investment in Series B - Aptinyx
Genesys Capital
Genesys Capital investment in Series B - Aptinyx
Adage Capital Management
Adage Capital Management investment in Series B - Aptinyx
Agent Capital
Agent Capital investment in Series B - Aptinyx
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Aptinyx
LVP Life Science Ventures
LVP Life Science Ventures investment in Series B - Aptinyx
Official Site Inspections
http://www.aptinyx.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.65 K
- Host name: 195.35.60.17
- IP address: 195.35.60.17
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin